KLRK1 and neoplasm: In conclusion, we suggest that adsorption apheresis of sNKG2DLs from patients’ plasma might be a promising combinatorial medical approach to overcome NKG2D-dependent tumor immune escape and to improve the efficacy of (cellular) cancer immunotherapy.